You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antibodies, monoclonal

Showing 51 - 75 of 7,894
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial in United States (TAK-981, Mezagitamab, Daratumumab and

Recruiting
  • Relapsed and/or Refractory Multiple Myeloma (RRMM)
  • Scottsdale, Arizona
  • +11 more
Jan 6, 2022

B-cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Hangzhou (QN-019a, Rituximab, Cyclophosphamid)

Recruiting
  • B-cell Lymphoma
  • B-cell Acute Lymphoblastic Leukemia
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical College of Zhejiang Uni
May 17, 2022

COVID-19 Trial in Minas Gerais, Bangkok, Samut Prakan (Favipiravir, Monoclonal antibodies, Ivermectin)

Recruiting
  • COVID-19
  • Minas Gerais, Brazil
  • +3 more
Feb 4, 2022

Ebola Virus Disease Trial in N'Zerekore (ansuvimab, Ervebo)

Not yet recruiting
  • Ebola Virus Disease
  • N'Zerekore, Guinea
    Centre de Traitement Ebola de N'Zerekore
Oct 14, 2021

Hematological Malignancies Trial in Hangzhou (NK cells/Combined Monoclonal Antibodies)

Not yet recruiting
  • Hematological Malignancies
  • NK cells/Combined Monoclonal Antibodies
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Dec 8, 2020

Antibody-mediated Rejection, Kidney Transplant; Complications, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)

Active, not recruiting
  • Antibody-mediated Rejection
  • +5 more
  • Los Angeles, California
    Norko Ammerman
Mar 25, 2022

NSCLC Trial in Shanghai (Capsulized Fecal Microbiota Transplant, Anti-programmed cell death protein 1/programmed death-ligand 1

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Capsulized Fecal Microbiota Transplant
  • +2 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Aug 12, 2021

Thrombocytopenia, Immune Thrombocytopenia, Myelodysplasia Trial in Pessac (Blood samples)

Recruiting
  • Thrombocytopenia
  • +2 more
  • Blood samples
  • Pessac, France
    CHU de Bordeaux - service de médecine interne
May 27, 2021

Corona Virus Disease Trial in United States (AZD7442, AZD8895 (clonal cell line material), AZD1061 (clonal cell line material))

Active, not recruiting
  • Corona Virus Disease
  • AZD7442
  • +4 more
  • Anniston, Alabama
  • +12 more
Aug 12, 2022

Open-label, Uncontrolled, Non-Interventional, Retrospective

Recruiting
  • Melanoma
  • Lung Cancer
  • Edegem, Belgium
    Universitair Ziekenhuis Antwerpen
Apr 23, 2021

Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma Trial in United States (FT538, Cyclophosphamide, Fludarabine)

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Denver, Colorado
  • +8 more
May 19, 2022

Covid19, COVID-19 Pneumonia, COVID-19 Respiratory Infection Trial in San Antonio (Ivermectin)

Recruiting
  • Covid19
  • +3 more
  • San Antonio, Florida
    Patrick Robinson MD LLC
Apr 25, 2022

Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in United States (FT596, Cyclophosphamide, Fludarabine)

Recruiting
  • Lymphoma, B-Cell
  • Chronic Lymphocytic Leukemia
  • Chicago, Illinois
  • +8 more
Jun 21, 2022

BIOmarkers of MIGraine:Proof of Concept Study Based on

Recruiting
  • Migraine
    • Hamburg, Germany
    • +2 more
    Apr 27, 2021

    HBV Trial in Paris (o receive treatment with anti-CD20 (rituximab or ocrelizumab) and to be vaccinated against hepatitis B)

    Recruiting
    • HBV
    • o receive treatment with anti-CD20 (rituximab or ocrelizumab) and to be vaccinated against hepatitis B
    • Paris, Ile De France, France
      Valérie POURCHER
    Feb 2, 2021

    Coronavirus Disease 2019 (COVID-19) Trial in United Kingdom, United States (AZD7442 (tixagevimab [AZD8895] + cilgavimab

    Active, not recruiting
    • Coronavirus Disease 2019 (COVID-19)
    • AZD7442 (tixagevimab [AZD8895] + cilgavimab [AZD1061])
    • Birmingham, Alabama
    • +15 more
    Nov 7, 2022

    Communicable Disease Transmission, Zoonotic Disease, Rabies Human Trial in Changchun City (recombinant anti-rabies human mAb

    Completed
    • Communicable Disease Transmission
    • +4 more
    • recombinant anti-rabies human monoclonal antibody injection (SYN023)
    • Rabies Vaccine
    • Changchun City, Jilin, China
      Jilin University
    Sep 23, 2021

    Lung Cancer, Surgery, Circulating Tumor Cell Trial in Amsterdam, Leiden (Cetuximab)

    Not yet recruiting
    • Lung Cancer
    • +2 more
    • Amsterdam, Netherlands
    • +1 more
    Oct 19, 2021

    Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in

    Not yet recruiting
    • Non-Hodgkin Lymphoma, B-cell
    • "novel" MAB (alone or in combination)
    • Viagrande, Catania, Italy
    • +57 more
    Aug 18, 2023

    Acute HIV Infection Trial in Brazil, Peru, United States (biological, other, drug)

    Not yet recruiting
    • Acute HIV Infection
    • VRC07-523LS
    • +3 more
    • Birmingham, Alabama
    • +35 more
    Jan 30, 2023

    Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

    Recruiting
    • Multiple Myeloma
    • Stem Cell Transplant
      • Firenze, Italy
      • +1 more
      Aug 19, 2021

      Ebola Virus Disease Trial in Sankt-Peterburg (Gamezumab)

      Recruiting
      • Ebola Virus Disease
      • Sankt-Peterburg, Russian Federation
        Research Institute of Influenza
      Feb 17, 2021

      HIV, Herpes Simplex Infections Trial in Providence (MB66, Placebo Film)

      Completed
      • HIV
      • Herpes Simplex Infections
      • Providence, Rhode Island
        The Miriam Hospital
      Apr 19, 2021

      Lymphoma Trial in Worldwide (immunoscintigraphy, technetium Tc 99m epratuzumab)

      Unknown status
      • Lymphoma
      • immunoscintigraphy
      • technetium Tc 99m epratuzumab
      • Los Angeles, California
      • +7 more
      Aug 12, 2021

      Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,

      Recruiting
      • Advanced Bladder Carcinoma
      • +34 more
      • Atezolizumab
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 29, 2022